Benfotiamine

Benfotiamine is a synthetic S-acyl derivative of thiamine (vitamin B1). It was developed in Japan in the late 1950s to treat alcoholic neuropathy, beriberi, Wernicke's encephalopathy, and other conditions related to thiamine deficiency.

Etymology

The term "Benfotiamine" is derived from the chemical structure of the compound, which is a benzoic acid derivative of thiamine. The "benfo-" prefix refers to the benzoic acid component, and "-thiamine" refers to the vitamin B1 component.

Pharmacology

Benfotiamine is converted by enzymes in the body to thiamine, which is then used in the production of energy and the maintenance of normal cellular functions. Unlike regular thiamine, benfotiamine is fat-soluble and therefore has a higher bioavailability and can be stored in the body for longer periods of time.

Medical Uses

Benfotiamine is used in the treatment of thiamine deficiency conditions such as beriberi, Wernicke's encephalopathy, and alcoholic neuropathy. It is also used in the management of diabetic neuropathy, a condition that affects the nerves in people with diabetes.

Side Effects

Common side effects of benfotiamine include nausea, vomiting, and diarrhea. Rare side effects can include allergic reactions such as rash, itching, and swelling.

Related Terms

• Thiamine: A water-soluble vitamin that plays a crucial role in certain metabolic reactions. Your body needs it to form adenosine triphosphate (ATP), which every cell of the body uses for energy.
• Neuropathy: A term that refers to general diseases or malfunctions of the nerves.
• Beriberi: A disease caused by a vitamin B-1 deficiency, also known as thiamine deficiency.
• Wernicke's encephalopathy: A neurological disorder characterized by the presence of Wernicke's triad: mental confusion, oculomotor dysfunction, and gait ataxia.

Benfotiamine Resources
Latest articles Most recent articles Ongoing trials	Wikipedia